After grabbing 27227.0 shares, the institutional investor is now in possession of 27227.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.64% having worth around $22598.0. Moreover, PGIM Quantitative Solutions LLC increased its share by 6400.0 to have a control over 19400.0 shares. And Two Sigma Securities LLC raised its holdings to 10921.0 shares by acquiring 10921.0 shares or 0.26% of the stake.
Histogen Inc. (HSTO) concluded trading on 01/18/23 at a closing price of $1.05, with 0.58 million shares of worth about $0.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -66.02% during that period and on Wednesday the price saw a gain of about 3.03%. Currently the company’s common shares owned by public are about 4.27M shares, out of which, 4.03M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analysts are covering the HSTO stock and their offered price forecasts bring an average price target of $5.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $5.00 and could fall to a lowest price of $5.00. The stock’s current price level is 79.0% above of average price target set by the analysts, while a rise to estimated low would result in gain of 79.0% for the stock. However, touching the estimated high of $5.00 would mean a gain of 79.0% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and Fidelity Nasdaq Composite Index F are the top 3 mutual funds which are holding stakes in Histogen Inc. Vanguard Extended Market Index Fu is currently holding 13638.0 shares of worth totaling $11320.0. The company recently came buying 0.0 shares which brought its stake up to 0.32% of the company’s outstanding shares. Fidelity Nasdaq Composite Index F, after buying 2611.0 shares, have now control over 0.06% of the stake in the company. It holds 0.0 shares of worth $2167.0.
Histogen Inc. (NASDAQ: HSTO) started trading at $1.0419, above $0.02 from concluding price of the previous day. However, the stock later moved at a day high price of 1.1500, or with a gain of 3.03%. Stock saw a price change of 0.00% in past 5 days and over the past one month there was a price change of 7.14%. Year-to-date (YTD), HSTO shares are showing a performance of 26.51% which decreased to -80.20% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.76 but also hit the highest price of $9.40 during that period. The average intraday trading volume for Histogen Inc. shares is 186.00K. The stock is currently trading 11.66% above its 20-day simple moving average (SMA20), while that difference is up 4.62% for SMA50 and it goes to -53.56% lower than SMA200.
Virtu Financial BD LLC acquired 27227.0 shares of Histogen Inc. having value of about $22598.0. Histogen Inc. (NASDAQ: HSTO) currently have 4.27M outstanding shares and institutions hold larger chunk of about 3.00% of that. Holding of mutual funds in the company is about 0.56% while other institutional holders and individual stake holders have control over 2.45% and 0.10% of the stake respectively.
The stock has a current market capitalization of $4.53M and its 3Y-monthly beta is at 1.20. It has posted earnings per share of -$4.30 in the same period. It has a debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HSTO, volatility over the week remained 11.65% while standing at 10.29% over the month.
Analysts are in expectations that Histogen Inc. (HSTO) stock would likely to be making an EPS of -$1.26 in the current quarter, while forecast for next quarter EPS is -$1.37 and it is -$0.8 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.26 which is -$1.26 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$1.8 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 81.30% while it is estimated to decrease by -36.90% in next year. EPS is likely to shrink at an annualized rate of 38.00% for next 5-years, compared to annual growth of 50.50% made by the stock over the past 5-years.
Analysts at 1 brokerage firms have issued recommendations for the Histogen Inc. (HSTO)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.